C69.50

Clinical Causes: Genetic mutations affecting tear gland cells Exposure to carcinogenic substances (e.g., certain chemicals or radiation) Prior radiation therapy to the head or eye area Chronic inflammation or irritation in the lacrimal gland Unknown etiology in many cases, highlighting the need for further research

Key Symptoms: Persistent swelling or a lump near the outer corner of the eye Pain or discomfort around the affected area Changes in eye appearance, such as protrusion or puffiness Impaired tear production leading to dryness or tearing abnormalities Visual disturbances or decreased vision Redness or inflammation around the eye Abnormal eye movements in advanced cases

Diagnosis Path: The diagnosis of a malignant neoplasm in the lacrimal gland or duct involves a comprehensive evaluation that may include: - Physical examination focusing on the eye and surrounding tissues - Imaging studies such as MRI or CT scans to determine the tumor’s size, location, and possible spread - Biopsy procedures to obtain tissue samples for histopathological analysis - Additional tests like ultrasound or orbital scintigraphy, as deemed necessary Medical professionals utilize these tools to establish the presence, type, and extent of malignancy, guiding subsequent treatment decisions.

Treatment Protocols: Treatment strategies for malignant neoplasm of the lacrimal gland and duct typically involve a combination of approaches tailored to the individual case. Common options include: - Surgical removal of the tumor, which may range from local excision to more extensive procedures like orbital exenteration in advanced stages - Radiation therapy aimed at destroying cancer cells and reducing tumor size - Chemotherapy, either systemic or localized, depending on the tumor’s characteristics and spread - Targeted therapy or immunotherapy, emerging options for certain cancer types Multidisciplinary care involving ophthalmologists, oncologists, and surgeons is essential for optimal management and improving outcomes.